Standard
Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis. / Petersen, Bodil; Bendtzen, Klaus; Koch-Henriksen, Nils; Ravnborg, Mads; Ross, Christian; Sorensen, Per Soelberg; Danish Multiple Sclerosis Group.
I:
Multiple Sclerosis, Bind 12, Nr. 3, 01.06.2006, s. 247-52.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Petersen, B, Bendtzen, K, Koch-Henriksen, N, Ravnborg, M, Ross, C, Sorensen, PS & Danish Multiple Sclerosis Group 2006, 'Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis', Multiple Sclerosis, bind 12, nr. 3, s. 247-52.
APA
Petersen, B., Bendtzen, K., Koch-Henriksen, N., Ravnborg, M., Ross, C., Sorensen, P. S., & Danish Multiple Sclerosis Group (2006). Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis, 12(3), 247-52.
Vancouver
Petersen B, Bendtzen K, Koch-Henriksen N, Ravnborg M, Ross C, Sorensen PS o.a. Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis. 2006 jun. 1;12(3):247-52.
Author
Petersen, Bodil ; Bendtzen, Klaus ; Koch-Henriksen, Nils ; Ravnborg, Mads ; Ross, Christian ; Sorensen, Per Soelberg ; Danish Multiple Sclerosis Group. / Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis. I: Multiple Sclerosis. 2006 ; Bind 12, Nr. 3. s. 247-52.
Bibtex
@article{42755c60a02c403f811d84e0e5979b39,
title = "Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis",
abstract = "The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.",
author = "Bodil Petersen and Klaus Bendtzen and Nils Koch-Henriksen and Mads Ravnborg and Christian Ross and Sorensen, {Per Soelberg} and Petersen, {Bodil Laub}",
year = "2006",
month = jun,
day = "1",
language = "English",
volume = "12",
pages = "247--52",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "SAGE Publications",
number = "3",
}
RIS
TY - JOUR
T1 - Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis
AU - Petersen, Bodil
AU - Bendtzen, Klaus
AU - Koch-Henriksen, Nils
AU - Ravnborg, Mads
AU - Ross, Christian
AU - Sorensen, Per Soelberg
AU - Danish Multiple Sclerosis Group
PY - 2006/6/1
Y1 - 2006/6/1
N2 - The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.
AB - The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.
M3 - Journal article
VL - 12
SP - 247
EP - 252
JO - Multiple Sclerosis Journal
JF - Multiple Sclerosis Journal
SN - 1352-4585
IS - 3
ER -
